Japan's Takeda To Partner With Envoy Of U.S. On Schizophrenia Drugs
This article was originally published in PharmAsia News
Executive Summary
Japan's Takeda Pharmaceutical and U.S. drug maker Envoy Therapeutics have signed an agreement to collaborate on developing schizophrenia drugs